You are here: Industry Insights > drug prices

News List

Pharma CEOs grilled by US Senators over drug prices pharmaphorum
February 28, 2019
Pharma bosses faced a grilling from the US Senate’s Finance Committee over the high price of branded prescription drugs in the US compared with other developed countries.
PCMA Releases Statement on Senate Finance Committee Hearing on Drug Prices americanpharmaceuticalreview
February 27, 2019
Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Finance Committee hearing, "Drug Pricing in America: A Prescription for Change, Part II:"....
US Senate invites seven pharma majors to testify on price hikes pharmaceutical-technology
February 19, 2019
A US Senate committee has written to seven major pharmaceutical companies, inviting them to testify at a hearing about increases to drug prices in the country....
Johnson & Johnson to disclose drug prices in television ads pharmaceutical-technology
February 13, 2019
Johnson & Johnson has announced plans to disclose the price of its prescription medicines directly to customers on TV advertisements in a bid to improve transparency.....
Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices fiercepharma
January 16, 2019
Biopharma experts predicting an M&A boom this year said one thing might thwart that surge of dealmaking: federal action on drug prices. If buyers can't charge what they want for the drugs they pick up in a merger, then the value of that deal could quickly
New California governor tackles drug prices in first act firstwordpharma
January 09, 2019
New California Governor Gavin Newsom signed an executive order directing state officials to create a single-purchaser system for prescription drugs, as reported NASDAQ Tuesday.
Pharma still puts pricing at the top of its worry list: report fiercepharma
January 08, 2019
It may not seem as if pharma companies are biting their nails over drug prices. After all, a cohort of drugmakers made headlines last week with an annual round of January hikes. But the issue is on the top of industry worries for 2019, a new report finds.
Federal proposal to force drug prices in TV ads draws big response from pharma, others fiercepharma
January 03, 2019
Four pharma companies chimed in among the 146 official comments on the federal government’s plan to tag pharma TV ads with drug prices. Pfizer, Eli Lilly, Sanofi and Johnson & Johnson filed commentary, along with the industry’s leading trade association,
Pharma companies break 2018 price freeze pharmaceutical-technology
January 03, 2019
On 1 January approximately 30 pharmaceutical companies raised the prices of hundreds of drugs in the US by an average of 6.3%, following a year of price freezes.
Pharma companies break 2018 price freeze pharmaceutical-technology
January 03, 2019
On 1 January approximately 30 pharmaceutical companies raised the prices of hundreds of drugs in the US by an average of 6.3%, following a year of price freezes.....

Previous page 1 2 3 4 Next page